Positive Mobilization Margins Alone Do Not Influence Survival Following Pancreatico-Duodenectomy for Pancreatic Ductal Adenocarcinoma

Jamieson, N. B., Foulis, A. K., Oien, K. A. , Going, J. J., Glen, P., Dickson, E. J., Imrie, C. W., McKay, C. J. and Carter, R. (2010) Positive Mobilization Margins Alone Do Not Influence Survival Following Pancreatico-Duodenectomy for Pancreatic Ductal Adenocarcinoma. Annals of Surgery, 251(6), pp. 1003-1010. (doi: 10.1097/SLA.0b013e3181d77369)

Abstract

Objective: To determine the prognostic influence of residual tumor at or within 1 mm of the mobilization margins (R1(Mobilization)) compared with transection margins (R1(Transection)) following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma (PDAC). Background: The prognostic strength of R1 status increases with frequency of margin positivity and is enhanced by protocol driven pathology reporting. Currently, margins are treated uniformly with tumor at or close to any margin considered of equal prognostic significance. The resection involves a mobilization phase freeing the posterior margin and anterior surface then a transection phase requiring lympho-vascular division forming the medial resection and pancreatic transection margin. The comparative assessment of the relative importance of tumor involvement of these different margins has not previously been investigated. Methods: Retrospective analysis of 148 consecutive resections for PDAC from 1996-2007 was performed. The individual (pancreatic transection, medial, posterior, and anterior surface) margins were separately identified and analyzed by a senior pathologist. An R1 resection was defined as microscopic evidence of tumor <= 1 mm from a resection margin. R1(Mobilization) tumor extension included both R1(Anterior) and R1(Posterior) cases; while R1(Transection) included pancreatic neck/body transection, R1(Medial) and adjacent transection margins. Results: R1 status was confirmed in 109 patients (74%). The medial (46%) and posterior (44%) margins were most commonly involved. R1 status was found to an independent predictor of poor outcome (P < 0.001). R1(Mobilization) involvement only (n = 48) was associated with a significantly longer median survival of 18.9 months (95% CI, 13.7-24.8) versus 11.1 months (95% CI, 7.1-15.0) for those with R1(Transection) tumor involvement (n = 61) (P < 0.001). There was no significant difference in the survival of the R1(Mobilization) compared with R0 group (P = 0.52). Conclusions: Following pancreaticoduodenectomy for PDAC, involvement of the transection margins in contrast to mobilization margins defines a group whose outcome is significantly worse. This may impact upon the allocation of adjuvant therapy within the setting of randomized controlled trials

• Item Type: Articles
• Keywords: adjuvant therapy CANCER CARCINOMA CONTROLLED-TRIAL CURATIVE RESECTION EXPERIENCE HEAD histopathology IMPACT INCREASE INDEPENDENT PROGNOSTIC-FACTOR INVOLVEMENT LH outcome PANCREATICODUODENECTOMY pathology PATIENT patients R1 RESECTIONS randomized controlled trials RANDOMIZED CONTROLLED-TRIAL RESECTION RESECTION MARGINS Scotland SURFACE SURGERY SURVIVAL THERAPIES THERAPY TRIAL trials UNIT
• Status: Published
• Refereed: Yes
• Glasgow Author(s) Enlighten ID: Jamieson, Professor Nigel and Foulis, Dr Alan and Oien, Professor Karin and Going, Dr James
• Authors: Jamieson, N. B., Foulis, A. K., Oien, K. A., Going, J. J., Glen, P., Dickson, E. J., Imrie, C. W., McKay, C. J., and Carter, R.
• College/School: College of Medical Veterinary and Life Sciences > School of Cancer Sciences
• Journal Name: Annals of Surgery
• Publisher: Lippincott, Williams & Wilkins
• ISSN: 0003-4932
• ISSN (Online): 1528-1140